Aflac

AFL

Market cap $57.5B

Overview Fund Activity

107.43 USD

-0.98

0.9%

At close Updated Sep 16, 1:10 PM EDT

1 day

-0.9%

5 days

1.48%

1 month

1.58%

3 months

4.59%

6 months

-0.89%

Year to date

4.95%

1 year

-2.49%

5 years

188.71%

10 years

265.16%

About: Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

Employees: 12,694

Financials Life Insurance

0

Funds holding %

of 7,463 funds

0

Analysts bullish %

of 7 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

117% more call options, than puts

Call options by funds: $364M | Put options by funds: $168M

7% more first-time investments, than exits

New positions opened: 126 | Existing positions closed: 118

0.34% more ownership

Funds ownership: 66.87% [Q1] → 67.21% (+0.34%) [Q2]

1% less funds holding

Funds holding: 1,606 [Q1] → 1,585 (-21) [Q2]

6% less capital invested

Capital invested by funds: $40.6B [Q1] → $38.3B (-$2.24B) [Q2]

23% less repeat investments, than reductions

Existing positions increased: 498 | Existing positions reduced: 645

30% less funds holding in top 10

Funds holding in top 10: 27 [Q1] → 19 (-8) [Q2]

See Fund Rankings

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$98

9% downside

Avg. target

$106

1% downside

High target

$113

5% upside

7 analyst ratings

0 positive

0%

5 neutral

71%

2 negative

29%

Morgan Stanley Nigel Dally	$113	Equal-Weight Maintained	18 Aug 2025
Evercore ISI Group Thomas Gallagher	$106	Underperform Maintained	15 Aug 2025
Wells Fargo Elyse Greenspan	$107	Equal-Weight Maintained	11 Aug 2025
Keefe, Bruyette & Woods Ryan Krueger	$108	Market Perform Maintained	11 Aug 2025
UBS Brian Meredith	$111	Neutral Maintained	6 Aug 2025
JP Morgan Jimmy Bhullar	$100	Neutral Maintained	8 Jul 2025
Barclays Alex Scott	$98	Underweight Maintained	7 Jul 2025

See Analyst Rankings

Financial journalist opinion

Based on 10 articles about AFL published over the past 30 days

Zacks Investment Research

3 Accident & Health Insurance Stocks to Watch Amid Pricing Pressure

Accident and Health Insurance stocks like AFL, TRUP and GL are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.

3 Accident & Health Insurance Stocks to Watch Amid Pricing Pressure

Aflac turns checkered pattern into a powerful reminder to "Check for Cancer"

Newly launched campaign teams up with sports broadcaster, fashion entrepreneur and cancer survivor Erin Andrews to urge Americans to prioritize early detection COLUMBUS, Ga. , Sept. 3, 2025 /PRNewswire/ -- Aflac, a leading provider of cancer insurance for nearly 70 years, working with sports broadcaster, fashion entrepreneur and cancer survivor Erin Andrews, today launched Check for Cancer, a national movement aimed at boosting U.S. cancer screening rates by 10% over the next decade.

Aflac turns checkered pattern into a powerful reminder to "Check for Cancer"

24/7 Wall Street

3 Dividend Growth Stocks That Can Double Your Income

Many investors focus on the dividend yield, but not much on the dividend growth.

3 Dividend Growth Stocks That Can Double Your Income

Amid college football uncertainty, the Aflac Duck takes charge as commissioner

Coach Saban and Coach Prime reunite with Aflac in annual college football campaign to help fans tackle the chaos of medical bills when health insurance falls short COLUMBUS, Ga. , Aug. 28, 2025 /PRNewswire/ -- Just as the college football landscape feels more unpredictable than ever, so too does the growing challenge of medical debt for Americans.

Amid college football uncertainty, the Aflac Duck takes charge as commissioner

Best Dividend Aristocrats For September 2025

Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 Aristocrats raising payouts in 2025 and an average growth rate of 5.14%, signaling continued income reliability. My 'Promising Aristocrats' list, focused on undervaluation and projected total return, has outperformed both NOBL and SPY in August.

Best Dividend Aristocrats For September 2025

Aflac: Best-In-Class Life Insurer Poised To Benefit From A Steepening Yield Curve

Buy Aflac for its high-interest rate sensitivity, superior financial strength, and best-in-class capital return strategy amid a steepening yield curve. Aflac's dominant Japan exposure, iconic brand, low debt/equity, and consistent dividend growth set it apart from peers like MetLife and Prudential. AFL offers a compelling 2.5x risk/reward to a $120 target (vs. $102 stop), supported by historical outperformance and a temporary slowdown in price momentum.

Aflac: Best-In-Class Life Insurer Poised To Benefit From A Steepening Yield Curve

Aflac: Q2 Earnings Indicate Slowing Growth (Rating Downgrade)

I am downgrading AFL to a hold due to slowing revenue and earnings growth and a premium valuation versus peers. AFL's Q2 results showed declining revenue and EPS, with investment losses and Japan segment weakness offsetting US segment growth. Despite a strong balance sheet and impressive dividend growth history, current valuation metrics limit near-term upside potential.

Aflac: Q2 Earnings Indicate Slowing Growth (Rating Downgrade)

Zacks Investment Research

All You Need to Know About Aflac (AFL) Rating Upgrade to Buy

Aflac (AFL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

All You Need to Know About Aflac (AFL) Rating Upgrade to Buy

Aflac study reveals the impact of paid leave on employers and employees

Nearly 3 in 4 employees experience workplace stress or anxiety while covering for a peer 1 COLUMBUS, Ga. , Aug. 21, 2025 /PRNewswire/ -- Key findings from the second annual Time Away Study 1 released by Aflac, the leading provider of health supplemental insurance in the U.S.,2 reveal the significant physical, mental and professional challenges faced by employees who assume additional work when a co-worker is on leave.

Aflac study reveals the impact of paid leave on employers and employees

Ex-Dividend Reminder: Loews, AFLAC And Marketaxess Holdings

On 8/20/25, Loews, AFLAC, and Marketaxess Holdings will all trade ex-dividend for their respective upcoming dividends. Loews will pay its quarterly dividend of $0.0625 on 9/2/25, AFLAC will pay its quarterly dividend of $0.58 on 9/2/25, and Marketaxess Holdings will pay its quarterly dividend of $0.76 on 9/3/25.

Ex-Dividend Reminder: Loews, AFLAC And Marketaxess Holdings

See News Rankings

Charts implemented using Lightweight Charts™